LYTIX BIOPHARMA ASA: årsregnskap 2004 vs 2003
Slipped into loss, fresh owner capital
Summary
What changed
Comparing Årsregnskap 2004 with 2003 for LYTIX BIOPHARMA ASA. Net result +770 NOK → -2 144 NOK. Equity 55 NOK → 3 799 NOK.
On the constructive side: equity strengthened; cash rose; owners injected capital. Pressures included: operating result weakened; fell into a net loss.
Mixed year — gains and pressures both show up.
At a glance
Scorecard
Operating result
+347 NOK
-2 152 NOK
-720.2%
Net result
+770 NOK
-2 144 NOK
-378.4%
Equity
55 NOK
3 799 NOK
+6807.3%
Cash
390 NOK
3 975 NOK
+919.2%
Total assets
708 NOK
5 142 NOK
+626.3%
What improved
-
↑
Equity strengthened
Book equity 55 NOK → 3 799 NOK (equity ratio 7.8% → 73.9%). Calculated
-
↑
Cash rose
Bank deposits 390 NOK → 3 975 NOK (+919.2% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 825 NOK → 5 943 NOK (+5 118 NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result +347 NOK → -2 152 NOK. Calculated
-
↓
Fell into a net loss
Net result flipped from 770 NOK profit to a loss of 2 144 NOK. Calculated